| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | JAMA - Journal of the American Medical Association | 2001 | 21.5K |
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Circulation | 2005 | 8K |
| Prediction of coronary heart disease using risk factor categories | Circulation | 1998 | 6.8K |
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | New England Journal of Medicine | 1995 | 6.3K |
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | New England Journal of Medicine | 2000 | 4.6K |
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Statistics in Medicine | 2008 | 4.5K |
| Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Circulation | 2004 | 4.5K |
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | New England Journal of Medicine | 1997 | 4.3K |
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Circulation | 2008 | 4.3K |
| High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study | American Journal of Medicine | 1977 | 4.1K |
| Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation | Diabetic Medicine | 2006 | 3.9K |
| Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Circulation | 2004 | 3.9K |
| Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study | JAMA - Journal of the American Medical Association | 1998 | 3.7K |
| Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study | Lancet, The | 1993 | 3.5K |
| The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men | JAMA - Journal of the American Medical Association | 2002 | 3.3K |
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Lancet, The | 2005 | 3.2K |
| Obesity | Lancet, The | 2005 | 3K |
| Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies | Lancet, The | 2009 | 3K |
| Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group | New England Journal of Medicine | 1999 | 2.8K |
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology | 2014 | 2.8K |
| Biological, clinical and population relevance of 95 loci for blood lipids | Nature | 2010 | 2.7K |
| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial | Lancet, The | 2005 | 2.4K |
| 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? | International Journal of Epidemiology | 2003 | 2.4K |
| Effects of torcetrapib in patients at high risk for coronary events | New England Journal of Medicine | 2007 | 2.3K |
| Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | American Journal of Respiratory and Critical Care Medicine | 2001 | 2.3K |
